| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $44.4M | +7.9% |
| SG&A Expense | $11.2M | -37.7% |
| Operating Income | -$55.6M | +5.9% |
| Interest Expense | $12K | +500.0% |
| Pre-tax Income | -$36.3M | +36.9% |
| Net Income | -$36.3M | +36.9% |
| EPS (Basic) | $27.76 | +2769.2% |
| EPS (Diluted) | $2.93 | +381.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $148.2M | +291.2% |
| Short-term Investments | $48.9M | -16.3% |
| Current Assets | $200.3M | +102.1% |
| Total Assets | $222.6M | +92.0% |
| Current Liabilities | $23.0M | +107.7% |
| Total Liabilities | $36.5M | +69.1% |
| Stockholders' Equity | $186.0M | +97.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$51.4M | -12.8% |
| Capital Expenditures | $321K | -71.1% |
| Investing Cash Flow | $25.6M | +143.4% |
| Financing Cash Flow | $92.5M | — |
| Free Cash Flow | -$51.7M | -10.8% |